buy
-
Financial
Greatbatch (GB) – Analysts’ Recent Ratings Change
By Maddie Sorenson Greatbatch (NYSE: GB) has recently received a number of price target changes and ratings updates: 8/29/2015 – Greatbatch had…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) GIVEN RATING OF 2.29 BY ANALYSTS
CONMED Corporation (NASDAQ:CNMD) shares have been an average broker rating (ABR) of 2.29 at Zacks Research. This is based on…
Read More » -
Financial
Integra Lifesciences Holdings Corp Stock Rating Reaffirmed by Piper Jaffray (IART)
By Thomas Dobrow Integra Lifesciences Holdings Corp (NASDAQ:IART)‘s stock had its “buy” rating reissued by equities researchers at Piper Jaffray in a…
Read More » -
Financial
Company Shares of Flexion Therapeutics, Inc. Drops by -8.02%
Flexion Therapeutics, Inc. (NASDAQ:FLXN) has dropped 8.02% during the past week, however, the bigger picture is still very bullish; the…
Read More » -
Financial
Oppenheimer: Time To Buy ConforMIS, Two Catalysts Are Coming Next Year Read more
By Monica Gerson In a report published Monday, Oppenheimer analyst Steven Lichtman initiated coverage of ConforMIS Inc CFMS 4.79% with an Outperform rating…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) ANALYST RATING UPDATE
Wall Street analysts polled by Zacks Research have given CONMED Corporation (NASDAQ:CNMD) a rating of 2 on a consensus basis.…
Read More » -
Financial
Aetna Buys Humana For $37 Billion, But Deal Doesn’t Add Up
By Dan Diamond The big are getting bigger: Aetna AET +1.74% and Humana HUM +0.62%, the nation’s number three and number four health insurers by revenue, are…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) STOCK RATING UPDATE
CONMED Corporation (NASDAQ:CNMD) has been issued a 2 rating by the sell-side brokerage firms covering the stock. Basing the rating…
Read More » -
Financial
Weekly Analysts’ Ratings Changes for Globus Medical (GMED)
By Samantha Reynolds Globus Medical (NASDAQ: GMED) recently received a number of ratings updates from brokerages and research firms: 5/7/2015 –…
Read More » -
Financial
Analysts Set Stryker Target Price at $95.88 (NYSE:SYK)
Stryker (NYSE:SYK) has received an average recommendation of “Buy” from the twenty-one ratings firms that are covering the company, Stock Ratings…
Read More » -
MAKO Surgical (MAKO) Shares Upgraded to a “Buy” Rating by Summer Street Analysts.
MAKO Surgical (NASDAQ: MAKO) was upgraded by equities research analysts at Summer Street from a “neutral” rating to a “buy” rating…
Read More »